Abstract
Gram-negative bacilli remain major killers of hospitalized patients and continue to evolve new resistance mechanisms. This review describes the mechanisms of resistance to beta-lactam antibiotics from those Gram-negative pathogens most often isolated from nosocomial infections.
MeSH terms
-
Animals
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use
-
Cross Infection / drug therapy*
-
Cross Infection / genetics
-
Gram-Negative Bacteria / drug effects
-
Gram-Negative Bacteria / genetics
-
Gram-Negative Bacterial Infections / drug therapy*
-
Gram-Negative Bacterial Infections / microbiology
-
Humans
-
beta-Lactam Resistance / drug effects
-
beta-Lactam Resistance / genetics*
-
beta-Lactams / pharmacology
-
beta-Lactams / therapeutic use*
Substances
-
Anti-Bacterial Agents
-
beta-Lactams